SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-19-001138
Filing Date
2019-03-12
Accepted
2019-03-12 16:37:01
Documents
93
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2237963z10-k.htm 10-K 2256724
2 EX-10.35 a2237963zex-10_35.htm EX-10.35 674741
3 EX-10.36 a2237963zex-10_36.htm EX-10.36 70040
4 EX-10.37 a2237963zex-10_37.htm EX-10.37 144199
5 EX-10.38 a2237963zex-10_38.htm EX-10.38 242321
6 EX-21.1 a2237963zex-21_1.htm EX-21.1 6076
7 EX-23.1 a2237963zex-23_1.htm EX-23.1 3326
8 EX-31.1 a2237963zex-31_1.htm EX-31.1 12662
9 EX-31.2 a2237963zex-31_2.htm EX-31.2 12525
10 EX-32.1 a2237963zex-32_1.htm EX-32.1 6475
11 EX-32.2 a2237963zex-32_2.htm EX-32.2 6497
18 G103848.JPG g103848.jpg GRAPHIC 76215
19 G301243KO01I001.GIF g301243ko01i001.gif GRAPHIC 3720
20 G301243KO03I001.JPG g301243ko03i001.jpg GRAPHIC 5865
  Complete submission text file 0001047469-19-001138.txt   11014669

Data Files

Seq Description Document Type Size
12 EX-101.INS nbrv-20181231.xml EX-101.INS 2219333
13 EX-101.SCH nbrv-20181231.xsd EX-101.SCH 66635
14 EX-101.CAL nbrv-20181231_cal.xml EX-101.CAL 72895
15 EX-101.DEF nbrv-20181231_def.xml EX-101.DEF 336829
16 EX-101.LAB nbrv-20181231_lab.xml EX-101.LAB 639708
17 EX-101.PRE nbrv-20181231_pre.xml EX-101.PRE 508070
Mailing Address 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406
Business Address 56 FITZWILLIAM SQUARE DUBLIN L2 2 (610) 816-6640
Nabriva Therapeutics plc (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37558 | Film No.: 19675554
SIC: 2834 Pharmaceutical Preparations